You just read:

Bird Rock Bio Announces Successful Completion of Phase 1B Safety Study and Readiness for Phase 2B Study of Nimacimab in Patients with Diabetic Kidney Disease

News provided by

Bird Rock Bio, Inc.

Oct 17, 2019, 09:00 ET